Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Aug 16:12:744290.
doi: 10.3389/fphar.2021.744290. eCollection 2021.

Editorial: Targeting the Chemoattractant System in Inflammation

Affiliations
Editorial

Editorial: Targeting the Chemoattractant System in Inflammation

Tadashi Hosoya et al. Front Pharmacol. .
No abstract available

Keywords: chemokine; complement; immunology; inflammation; lipid mediator.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Targeting the Chemoattractant System in Inflammation

References

    1. Aletaha D., Smolen J. S. (2018). Diagnosis and Management of Rheumatoid Arthritis. JAMA 320, 1360–1372. 10.1001/jama.2018.13103 - DOI - PubMed
    1. Angelini A., Miyabe Y., Newsted D., Kwan B. H., Miyabe C., Kelly R. L., et al. (2018). Directed Evolution of Broadly Crossreactive Chemokine-Blocking Antibodies Efficacious in Arthritis. Nat. Commun. 9, 1461. 10.1038/s41467-018-03687-x - DOI - PMC - PubMed
    1. Chan M., Ahmadi A., Yao S., Sato-Kaneko F., Messer K., Pu M., et al. (2017). Identification of Biologically Active Pyrimido[5,4-B]indoles that Prolong NF-κB Activation without Intrinsic Activity. ACS Comb. Sci. 19, 533–543. 10.1021/acscombsci.7b00080 - DOI - PMC - PubMed
    1. Gao H., Kang N., Hu C., Zhang Z., Xu Q., Liu Y., et al. (2020). Ginsenoside Rb1 Exerts Anti-inflammatory Effects In Vitro and In Vivo by Modulating Toll-like Receptor 4 Dimerization and NF-kB/MAPKs Signaling Pathways. Phytomedicine 69, 153197. 10.1016/j.phymed.2020.153197 - DOI - PubMed
    1. Gupta S., Leaf D. E. (2021). Tocilizumab in COVID-19: Some Clarity amid Controversy. Lancet 397, 1599–1601. 10.1016/s0140-6736(21)00712-1 - DOI - PMC - PubMed

Publication types

LinkOut - more resources